A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Health providers say that widespread confusion about the pause and its potential impact on patients was already making it ...

Martin, M.D., M.H.S., FAHA, a professor of medicine and cardiologist at Johns Hopkins School of Medicine in Baltimore ... a professor of cardiovascular medicine at Stanford University in Palo Alto, ...

Stanford University; Intermountain Health; Beth Israel Deaconess Medical Center; Icahn School of Medicine at Mount Sinai; Columbia University; RECOVER Patient, Caregiver or Community ...

Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...

Dr. Yeh will oversee the continued clinical development of NGM Bio’s key programs, NGM120 for hyperemesis gravidarum and cancer cachexia, and ...

Researchers from NYU Langone Health and NYU Grossman School of Medicine are part of a major ... at the Byers Eye Institute at Stanford University, will serve as principal investigator for the ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have ... Evans Foundation; Gabrielle's Angel Foundation; Stanford Maternal Child Health Research ...

A Medical Mystery” and “The Body Transplant” among other novels, radiology professor Heike Daldrup-Link uses storytelling to ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Correspondence to Professor Robert K Jackler, Stanford Research into The Impact of Tobacco Advertising, 801 Welch Road, Stanford University School of Medicine, Stanford ... ‘Puff’ brand name and ...